Bispecific Antibody

Explore how bispecific antibodies (BsAbs) revolutionize in vivo research, enhancing oncology, immunotherapy, & drug development with dual-targeting precision.

Explore how bispecific antibody-drug conjugates (bsADCs) combine dual-targeting antibodies with cytotoxic payloads, advancing cancer treatment with enhanced precision.

Explore bispecific antibodies: dual-antigen targeting, IgG-like & non-IgG-like formats, innovative design techniques, & transformative applications in cancer immunotherapy.

Learn about bispecific antibodies (bsAbs), their history, advantages over monoclonal antibodies, and popular formats like knobs-into-holes and BiTE.

Discover Biointron's expertise in producing bispecific antibodies using advanced methods like knobs-in-holes, Ig-scFv fusion, & Diabody-Fc fusion for innovative therapies.

Discover advancements in antibody engineering, from bispecifics to Fc optimization & humanization, driving innovations in therapeutic antibody development.